Synthesis and Physiological Activity of Novel Berberine Derivatives

Xiao-fei JIANG; Jiu-hui LIU; Hu LI; Wei ZHANG; Heng LUO

doi:10.13422/j.cnki.syfjx.20192115

您当前的位置：

首页 >

文章列表页 >

Synthesis and Physiological Activity of Novel Berberine Derivatives

Resource and Quality Evaluation | 更新时间：2021-02-09

- Synthesis and Physiological Activity of Novel Berberine Derivatives
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 23, Pages: 156-164(2019)
- 作者机构：
  
  1.贵州师范学院　化学与材料学院，贵阳　 551088；
  2.贵州师范学院　地理与旅游环境学院，贵阳　 551088；
  3.贵州省中国科学院天然产物化学重点实验室，贵阳　 550014
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20192115
  CLC： R914.5; R284.2; R289; R22
- Received：19 June 2019，
  
  Published Online：18 July 2019，
  
  Published：05 December 2019
- 稿件说明：
移动端阅览
Xiao-fei JIANG, Jiu-hui LIU, Hu LI, et al. Synthesis and Physiological Activity of Novel Berberine Derivatives[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(23): 156-164.
DOI：

Xiao-fei JIANG, Jiu-hui LIU, Hu LI, et al. Synthesis and Physiological Activity of Novel Berberine Derivatives[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(23): 156-164. DOI： 10.13422/j.cnki.syfjx.20192115.

摘要

目的：

以具有多种生理活性的小檗碱为原料合成新型衍生物，并研究其细胞增殖抑制作用，抑制乙酰胆碱酯酶和丁酰胆碱酯酶的活性。

方法：

运用药效团整合策略将具有多种生理活性的小檗碱与抑制组蛋白去乙酰化酶的药效团异羟肟酸、邻苯二胺、巯基进行拼合，通过有机合成手段得到了7个文献未见报道的小檗碱新型衍生物，通过核磁共振氢谱(

H-NMR)，碳谱(

C-NMR)和质谱(MS)进行结构表征，并采用噻唑蓝(MTT)比色法检测了7种小檗碱衍生物对人结肠癌细胞(HCT116)，人肝癌细胞(HepG2)，人宫颈癌细胞(HeLa)，人急性淋巴白血病细胞(CCRF-CEM)的增殖活性，采用

Ellman

法对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)抑制活性进行了测试。

结果：

含甲基酮的小檗碱衍生物同时具有较好细胞增殖抑制作用，抑制乙酰胆碱酯酶的活性，化合物5b对CCRF-CEM细胞株的版抑制浓度(IC

)达到了1.48 μmol·L

－1

，对乙酰胆碱酯酶的抑制活性IC

为(0.38±0.004)μmol·L

－1

，明显高于先导化合物小檗碱。

结论：

目标化合物的合成路线为此类生物碱衍生物的合成与活性研究提供了参考，其中化合物5b细胞增殖抑制作用和乙酰胆碱酯酶抑制活性较强，后续值得进一步研究。

Abstract

Objective:

TO synthesize novel berberine derivatives with a variety of physiological activities

and study their antitumor activity and acetylcholinesterase inhibitory activity.

Method:

Berberines with a variety of physiological activities were pieced together isohydroxamic acid

-phenylenediamine

and sulfhydryl pharmacophore with effects in inhibiting histones and removing acetylases. Totally 7 novel berberine derivatives were obtained by means of organic synthesis. The structures of these derivatives were characterized and confirmed by

H-NMR

C-NMR and MS spectral data.Thiazolyl blue tetrazolium bromide(MTT) method was used in the determination of the cytotoxic activity of HCT116

HepG2

HeLa and CCRF-CEM human cancer cell lines

in vitro

Ellman

method was used to reveal the inhibitory activities of acetylcholinesterase and butyrylcholinesterase.

Result:

The results showed that the berberine derivatives containing methyl ketone had good antitumor and acetylcholinesterase inhibitory activities. The results demonstrated that compound 5bhad the highest anti-proliferative activity against CCRF-CEM cell line and the acetylcholinesterase inhibitory activities

with IC

=1.48 μmol·L

-1

and IC

=0.38 μmol·L

-1

respectivly.

Conclusion:

This paper provides a reference for the synthesis and biological evaluation of this kind of alkaloid derivatives. Compound 5bis a promising candidate drug and worth further study.

关键词

Keywords

references

王忠雷，张小华，杨丽燕，等．拼合原理在降血糖新药研发中的应用设想 [J]．中国实验方剂学杂志， 2013 ， 19 ( 4 )： 351 - 354 ．

Grycovã L , Dostã I J , Marek R . Quaternary protoberberine alkaloids [J]. Phytochemistry , 2006 , 68 ( 2 ): 150 - 175 .

LIN C C , Ng L T , Hsu F F , et al . Cytotoxic effect, of Coptis chinensis and Epimedium sagittatum extracts and their major constituents(berberine, coptisine and icariin) on hepatoma and leukaemia cell growth [J]. Clin Exp Pharmacol Physiol , 2004 , 31 ( 1/2 ): 65 - 69 .

Manfredi K P , Blunt J W , Cardellina J H , et al . Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2 [J]. J Med Chem , 1991 , 34 ( 12 ): 3402 - 3405 .

Lee S , Lim H J , Park J H , et al . Berberine-induced LDLR up-regulation involves JNK pathway [J]. Biochem Biophys Res Commun , 2007 , 362 ( 4 ): 853 - 857 .

YAN F , Benrong H , QIANG T , et al . Hypoglycemic activity of jatrorrhizine [J]. J Huazhong Univ Sci Technolog Med Sci , 2005 , 25 ( 5 ): 491 - 493 .

任妍林，王定坤，董慧，等．小檗碱治疗糖尿病肾病的研究进展 [J]．中国中药杂志， 2017 ， 42 ( 3 )： 438 - 442 ．

丁阳平，叶小利，周洁，等．小檗碱衍生物合成及生理活性研究进展 [J]．有机化学， 2012 ， 32 ( 4 )： 677 - 685 ．

Bolden J E , Peart M J , Johnstone R W . Anticancer activities of histone deacetylase inhibitors [J]. Nat Rev Drug Discov , 2006 , 5 ( 9 ): 769 - 784 .

ZHANG L , SHENG S , QIN C . The role of HDAC6 in Alzheimer' s disease [J]. J Alzheimers Dis , 2013 , 33 ( 2 ): 283 - 295 .

赵建伟，张静竹，安丽．莱菔硫烷对阿尔茨海默病的拮抗作用及其机制研究 [C]// 2018环境与健康学术会议—精准环境健康：跨学科合作的挑战论文汇编，沈阳， 2018 ： 385 - 386 ．

Patel J H , DU Y , Ard P G , et al . The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60 [J]. Mol Cell Biol , 2004 , 24 ( 24 ): 10826 - 10834 .

Mahboobi S , Sellmer A , Winkler M , et al . Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor(EGFR), human epidermal growth factor receptor 2(HER2), and histone deacetylase activity [J]. J Med Chem , 2010 , 53 ( 24 ): 8546 - 8555 .

Bérubé , Gervais . An overview of molecular hybrids in drug discovery [J]. Expert Opin Drug Dis , 2016 , 11 ( 3 ): 281 - 305 .

毕重文，张彩霞，李阳彪，等．环化小檗碱类似物的合成及其抗肿瘤活性研究 [J]．药学学报， 2013 ， 48 ( 12 )： 1800 - 1806 ．

SHI A , HUANG L , LU C , et al . Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors [J]. Bioorg Med Chem , 2011 , 48 ( 12 ): 2298 - 2305 .

任杰，祁燕杰，胡昆，等．萝卜硫素衍生物及其制备方法和用途：中国， CN 102775336 A [P]． 2012 ．

赵育，倪春燕，张虞婷，等．山荷叶素异羟肟酸和硫醇衍生物的合成与抑制肿瘤细胞增殖活性 [J]．有机化学， 2013 ， 33 ( 1 )： 169 - 173 ．

CHEN J X , LIN W E , CHEN M Z , et al . Synthesis, characterization and potent DNA-cleaving activity of copper(II)-complexed berberine carboxylate [J]. Bioorg Med Chem Lett , 2012 , 22 ( 23 ): 7056 - 7059 .

CHEN L , Wilson D , Jayaram H N , et al . Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment [J]. J Med Chem , 2007 , 50 ( 26 ): 6685 - 6691 .

GAO G , Mclean T , CHEN L , et al . Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure [J]. Bioorg Med Chem , 2010 , 18 ( 16 ): 5950 - 5964 .

LI X , Inks E S , LI X , et al . Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity [J]. J Med Chem , 2014 , 57 ( 8 ): 3324 - 3341 .

Ellman G L , Courtney K D , Jr A V , et al . A new and rapid colorimetric determination of acetylcholinesterase activity [J]. Biochem Pharmacol , 1961 , 7 ( 2 ): 88 - 95 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Synthesis and Anti-tumor Activity of New Rotundic Acid Derivatives

Synthesis,Characterization and Antibacterial Activities of Curcumin Derivatives

Prevention and Treatment of Colorectal Cancer Through Traditional Chinese Medicine Targeted Wnt Signaling Pathway： A Review

Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease：A Review

Pharmacological Effect of Berberine on Alzheimer's Disease： A Review

Related Author

Min-lun NAN

Yu-fang HE

Xue-ling SI

Yu-wei ZHAO

Xue WANG

Xue BAI

Chuan-jing LI

ZHONG Yi-ning1

Related Institution

Jilin Agricultural University

Xiuzheng Pharmaceutical Changchun Hi-tech Pharmaceutical Co.Ltd.

Academy of Chinese Medical Sciences of Jilin Province

Changchun University of Chinese Medicine

Changzhou Hospital of Traditional Chinese Medicine（TCM）

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰